
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5552335
[patent_doc_number] => 20090286321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/363498
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 65754
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286321.pdf
[firstpage_image] =>[orig_patent_app_number] => 12363498
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363498 | METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS | Jan 29, 2009 | Abandoned |
Array
(
[id] => 5421956
[patent_doc_number] => 20090148411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/363454
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 65737
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148411.pdf
[firstpage_image] =>[orig_patent_app_number] => 12363454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363454 | VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS | Jan 29, 2009 | Abandoned |
Array
(
[id] => 5422494
[patent_doc_number] => 20090148949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'rAAV Expression Systems and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/363469
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 65746
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148949.pdf
[firstpage_image] =>[orig_patent_app_number] => 12363469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363469 | rAAV Expression Systems and Methods of Use | Jan 29, 2009 | Abandoned |
Array
(
[id] => 7742438
[patent_doc_number] => 20120021043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant'
[patent_app_type] => utility
[patent_app_number] => 12/672442
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 37845
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672442 | Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvant | Jan 27, 2009 | Issued |
Array
(
[id] => 5435605
[patent_doc_number] => 20090170192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'METHODS AND DNA CONSTRUCTS FOR HIGH YIELD PRODUCTION OF POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/358966
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27206
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358966 | Methods and DNA constructs for high yield production of polypeptides | Jan 22, 2009 | Issued |
Array
(
[id] => 10026270
[patent_doc_number] => 09068160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Methods of producing an antisense viral particle population'
[patent_app_type] => utility
[patent_app_number] => 12/863351
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4797
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863351 | Methods of producing an antisense viral particle population | Jan 15, 2009 | Issued |
Array
(
[id] => 5392124
[patent_doc_number] => 20090209437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'TEMPERATURE REGULATED PROMOTERS FROM SCHIZOSACCHAROMYCES POMBE FOR EXPRESSION OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/329167
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7920
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209437.pdf
[firstpage_image] =>[orig_patent_app_number] => 12329167
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329167 | TEMPERATURE REGULATED PROMOTERS FROM SCHIZOSACCHAROMYCES POMBE FOR EXPRESSION OF PROTEINS | Dec 4, 2008 | Abandoned |
Array
(
[id] => 6270467
[patent_doc_number] => 20100254947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/744375
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22708
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744375 | Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof | Nov 23, 2008 | Issued |
Array
(
[id] => 6270467
[patent_doc_number] => 20100254947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/744375
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22708
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744375 | Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof | Nov 23, 2008 | Issued |
Array
(
[id] => 6339691
[patent_doc_number] => 20100247490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38'
[patent_app_type] => utility
[patent_app_number] => 12/744441
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22328
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247490.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744441 | Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 | Nov 23, 2008 | Issued |
Array
(
[id] => 6270467
[patent_doc_number] => 20100254947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/744375
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22708
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744375 | Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof | Nov 23, 2008 | Issued |
Array
(
[id] => 9375971
[patent_doc_number] => 08680236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Altered OspA of borrelia burgdorferi '
[patent_app_type] => utility
[patent_app_number] => 12/313443
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 138
[patent_figures_cnt] => 142
[patent_no_of_words] => 24244
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12313443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313443 | Altered OspA of borrelia burgdorferi | Nov 18, 2008 | Issued |
Array
(
[id] => 9286013
[patent_doc_number] => 08642341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Materials and methods for gene mediated therapy of psychiatric disorders'
[patent_app_type] => utility
[patent_app_number] => 12/740725
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740725 | Materials and methods for gene mediated therapy of psychiatric disorders | Oct 30, 2008 | Issued |
Array
(
[id] => 5391724
[patent_doc_number] => 20090209037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Viral core protein-cationic lipid-nucleic acid-delivery complexes'
[patent_app_type] => utility
[patent_app_number] => 12/261999
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16533
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12261999
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/261999 | Viral core protein-cationic lipid-nucleic acid-delivery complexes | Oct 29, 2008 | Abandoned |
Array
(
[id] => 5409570
[patent_doc_number] => 20090123468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM'
[patent_app_type] => utility
[patent_app_number] => 12/253138
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12023
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123468.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253138
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253138 | TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM | Oct 15, 2008 | Abandoned |
Array
(
[id] => 5374227
[patent_doc_number] => 20090311788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'MULTIPLE-COMPARTMENT EUKARYOTIC EXPRESSION SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 12/245431
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35617
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311788.pdf
[firstpage_image] =>[orig_patent_app_number] => 12245431
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/245431 | MULTIPLE-COMPARTMENT EUKARYOTIC EXPRESSION SYSTEMS | Oct 2, 2008 | Abandoned |
Array
(
[id] => 9711051
[patent_doc_number] => 08835621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Synthetic 5\'UTRs, expression vectors, and methods for increasing transgene expression'
[patent_app_type] => utility
[patent_app_number] => 12/681609
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 16631
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681609
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681609 | Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression | Sep 25, 2008 | Issued |
Array
(
[id] => 6623242
[patent_doc_number] => 20100311123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'VECTOR FOR EXPRESSING ANTIBODY FRAGMENTS AND A METHOD FOR PRODUCING RECOMBINANT PHAGE THAT DISPLAYS ANTIBODY FRAGMENTS BY USING THE VECTOR'
[patent_app_type] => utility
[patent_app_number] => 12/682880
[patent_app_country] => US
[patent_app_date] => 2008-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14583
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311123.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682880
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682880 | VECTOR FOR EXPRESSING ANTIBODY FRAGMENTS AND A METHOD FOR PRODUCING RECOMBINANT PHAGE THAT DISPLAYS ANTIBODY FRAGMENTS BY USING THE VECTOR | Sep 3, 2008 | Abandoned |
Array
(
[id] => 5428102
[patent_doc_number] => 20090087412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression'
[patent_app_type] => utility
[patent_app_number] => 12/231311
[patent_app_country] => US
[patent_app_date] => 2008-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29053
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20090087412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231311 | Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression | Sep 1, 2008 | Abandoned |
Array
(
[id] => 9523600
[patent_doc_number] => 08747861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Multimeric multiepitope influenza vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/671617
[patent_app_country] => US
[patent_app_date] => 2008-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 16379
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12671617
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671617 | Multimeric multiepitope influenza vaccines | Aug 2, 2008 | Issued |